Purchase Order 36C25621P1517
- Not listed
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the drug Ruzurgi (amifampridine) 10 mg tablets with a potential value of $136,387.44. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialty pharmacy focused on rare diseases that has received multiple federal contract awards from the Department of Justice Bureau of Prisons and the...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency provision of TARPEYO 4mg prescription medication, with a ceiling value of $10,896.98 and a performance period ending on November 2, 2025. The contract was awarded on October 2, 2025, and does not have a set-aside...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $10,896.98, is for the supply of TARPEYO 4MG (NDC 81749-0004-01), an emergency pharmaceutical product, to the VA's Veterans Integrated Service Network (VISN) 2. The contract has an ultimate completion date of July 30, 2025. Pantherx Specialty is the prime contractor,...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO 4mg capsules to the New York Harbor, Margaret Cochran Corbin VA Medical Center. The contract has a ceiling value of $10,896.98 and a period of performance ending on...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG, a prescription medication, to the New York Harbor VA Medical Center. The contract has a ceiling value of $10,896.98 and an ultimate completion date of June 23, 2025. The contract does...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on October 16, 2025, for TARPEYO 4mg (budesonide), a specialized pharmaceutical product. The contract carries a ceiling value of $10,896.98 and is scheduled for completion by November 17, 2025. This award was not issued under any set-aside designation. Pantherx Specialty, a Pittsburgh-based specialty...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
- This is a federal contract award to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the U.S. Department of Veterans Affairs (VA) for the delivery of pharmaceutical products. The contract has a total ceiling value of $293,518.80 and a completion date of December 14, 2024. It is a firm fixed-price delivery order contract issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Recordati Rare Diseases Inc. specializes in developing...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Paragon Enterprises Inc., doing business as Paragonmeds, for the delivery of various pharmaceutical products to VA Consolidated Mail Outpatient Pharmacies, medical centers, and logistics facilities across multiple states. The contract, valued at $151,476.00, was awarded on December 8, 2020 with a completion date of December 22, 2020. The products delivered under...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a subsidiary of Centene Corporation, to provide the drug Ruzurgi 10mg. The contract has a ceiling value of $85,242.15 and an ultimate completion date of February 13, 2022. No set-aside designation was used for this award. Pantherx Specialty, a specialty pharmacy focused on rare diseases, has received multiple federal contracts from the Department of Justice Bureau of Prisons and the VA to supply prescription medications to various government healthcare facilities, supporting the medical needs of federal inmates and veterans. This contract allows the VA to obtain the Ruzurgi drug, which provides treatment to veterans receiving care through the VA health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($34k) | 7/26/23 | |
| Not listed | Not listed | $119.5k | 8/18/21 |